Table 4.
Comparison of LMR, NLR, PLR and blood count of patients with THYR3B with benign or malignant pathology.
| Benign 156 pts |
Malignant 59 pts |
p | |
|---|---|---|---|
| White Blood Cell (U/µL) | 5959.06 ± 2169.93 | 5543.35 ± 2289.12 | 0.222 |
| Neutrophils (U/µL) | 3751.19 ± 429.26 | 3884.3 ± 416.38 | 0.047 |
| Lymphocytes (U/µL) | 1848.04 ± 340.47 | 1678.64 ± 318.78 | 0.001 |
| Monocytes (U/µL) | 306.56 ± 66.10 | 314.64 ± 63.97 | 0.419 |
| Platelets (U/µL) | 239,400.35 ± 52,263.05 | 230,379.69 ± 51,889.76 | 0.249 |
| LMR | 6.33 ± 1.89 | 5.56 ± 1.58 | 0.003 |
| NLR | 2.09 ± 0.46 | 2.39 ± 0.49 | <0.0001 |
| PLR | 134.9 ± 41.91 | 143.28 ± 46.54 | 0.227 |
Values are expressed as mean ± standard deviation. NLR (neutrophil-to-lymphocyte ratio), PLR (platelet-to-lymphocyte ratio), LMR (lymphocyte-to-monocyte ratio).